Acute and Chronic Gastritis and the Role of Proper Nutrition
Keywords:
healthy nutrition, prevention, digestive system, acute and chronic gastritis, dietary tablesAbstract
Acute and chronic gastritis are among the most common diseases of the digestive system and are characterized by inflammation of the gastric mucosa caused by various external and internal factors. Improper dietary habits, Helicobacter pylori infection, alcohol consumption, certain medications, and unhealthy lifestyle factors play an important role in the development and progression of these conditions. This article analyzes the clinical characteristics, etiological factors, and pathological mechanisms of acute and chronic gastritis and highlights the importance of proper nutrition in their prevention and management. Special attention is given to the role of therapeutic dietary tables, particularly Diet No.1, which is widely used in the treatment of gastritis and gastric ulcer disease. The study also discusses the impact of aggressive foods, irregular meal patterns, and nutritional deficiencies on gastric mucosal damage. Based on the analysis of scientific literature and epidemiological data, the article emphasizes that balanced nutrition and adherence to dietary recommendations significantly contribute to reducing inflammation, improving digestive function, and preventing complications associated with gastritis. The findings underline the importance of diet therapy as an essential component in the comprehensive management of gastritis and in maintaining overall gastrointestinal health.
References
[1] Y. Zhang, H. Li, and J. Wang, “A computer-assisted diagnosis system for the detection of chronic gastritis in endoscopic images using a novel convolution and relative self-attention parallel network,” IEEE Access, 2023, doi:10.1109/ACCESS.2023.3326540.
[2] A.G. Gadayev, M.Sh. Karimov, and X.S. Axmedov, Ichki kasalliklar propedevtikasi. Toshkent, Uzbekistan: Tibbiyot Nashriyoti, 2023.
[3] J.K.Y. Hooi et al., “Global prevalence of Helicobacter pylori infection between 1980 and 2020: a systematic review and meta-analysis,” The Lancet Gastroenterology & Hepatology, vol. 8, no. 6, pp. 553-564, 2023, doi:10.1016/S2468-1253(23)00070-5.
[4] J.A. Rizaev, A.G. Gadaev, and L.S. Maxmanov, “Helicobacter pylori bilan assotsiyalangan temir va vitamin B12 tanqisligi kamqonliklariga moyillik tug‘diruvchi ayrim tashqi omillarni o‘rganish,” Tibbiyot Axborotnomasi, 2022, doi:10.38095/2181-466X-20221063-94-101.
[5] Sh.S. Narziyev and M. Abdullayeva, Ichki kasalliklar propedevtikasi. Buxoro, Uzbekistan, 2018.
[6] J. Feldman, L.S. Friedman, and L.J. Brandt, Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Philadelphia, USA: Elsevier, 2021.
[7] M. Talley and N. Ford, “Functional dyspepsia and gastritis: clinical aspects and management,” The Lancet, vol. 394, pp. 1660-1670, 2019.
[8] B.G. Katzung and A.J. Trevor, Basic and Clinical Pharmacology. New York, USA: McGraw-Hill Education, 2021.
[9] J. Warren and B. Marshall, “Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration,” The Lancet, vol. 323, pp. 1311-1315, 1984.
[10] World Health Organization, Guidelines for the Management of Helicobacter pylori Infection. Geneva, Switzerland: WHO Press, 2022.
[11] R.H. Hunt, S.D. Xiao, and F. Megraud, “Helicobacter pylori in developing countries,” World Gastroenterology Organisation Global Guidelines, 2019.
[12] P. Malfertheiner et al., “Management of Helicobacter pylori infection – the Maastricht V/Florence Consensus Report,” Gut, vol. 66, pp. 6-30, 2017.
[13] L.L. Brunton, R. Hilal-Dandan, and B.C. Knollmann, Goodman & Gilman’s The Pharmacological Basis of Therapeutics. New York, USA: McGraw-Hill, 2018.
[14] M. Camilleri and A.C. Ford, “Dietary management of gastrointestinal disorders,” Nature Reviews Gastroenterology & Hepatology, vol. 17, pp. 453-464, 2020.
[15] A.C. Guyton and J.E. Hall, Textbook of Medical Physiology. Philadelphia, USA: Elsevier, 2021.
